Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Luo L, Du T, Zhang J, et al. Int J Nanomedicine. 2016;11:501—513. The authors have advised due to an error at the time of figure assembly, Figure 11 on page 510 is incorrect. The correct Figure 11 is shown below. The authors apologize for this error and advise it...
Main Authors: | Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-efficient-inhibition-of-ovarian-cancer-by-degradable-nanop-peer-reviewed-article-IJN |
Similar Items
-
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
by: Luo L, et al.
Published: (2016-02-01) -
Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis
by: Beata Gąsowska-Bajger, et al.
Published: (2021-02-01) -
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
by: Felisiak-Golabek Anna, et al.
Published: (2011-11-01) -
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
by: Silvia Martini, et al.
Published: (2021-05-01) -
Regulation of Survivin Isoform Expression by GLI Proteins in Ovarian Cancer
by: Diana Trnski, et al.
Published: (2019-02-01)